Replacement of dietary saturated fat with trans fat reduces serum paraoxonase activity in healthy men and women.

No abstract is available for this paper.

• Publication year

  2002

• Venue

  Metabolism: Clinical and Experimental

• Publication date

  2002-12-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1053/META.2002.36305PMID 12489064
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Paraoxonase and coronary heart disease.

  2002cited by this paper
• Replacement of Dietary Saturated Fatty Acids by Trans Fatty Acids Lowers Serum HDL Cholesterol and Impairs Endothelial Function in Healthy Men and Women

  2001cited by this paper
• Consumption of a solid fat rich in lauric acid results in a more favorable serum lipid profile in healthy men and women than consumption of a solid fat rich in trans-fatty acids.

  2001cited by this paper
• Normal high density lipoprotein inhibits three steps in the formation of mildly oxidized low density lipoprotein: step 1.

  2000cited by this paper
• Paraoxonase activity in two healthy populations with differing rates of coronary heart disease

  2000cited by this paper
• Dietary fat modulates serum paraoxonase 1 activity in rats.

  2000cited by this paper
• Pomegranate juice consumption reduces oxidative stress, atherogenic modifications to LDL, and platelet aggregation: studies in humans and in atherosclerotic apolipoprotein E-deficient mice.

  2000cited by this paper
• Effect of Simvastatin Therapy on Paraoxonase Activity and Related Lipoproteins in Familial Hypercholesterolemic Patients

  2000cited by this paper
• Paraoxonase polymorphism (Gln192Arg) as a determinant of the response of human coronary arteries to serotonin.

  2000cited by this paper
• Smoking is associated with reduced serum paraoxonase activity and concentration in patients with coronary artery disease.

  2000cited by this paper
• Paraoxonase (PON1) Phenotype Is a Better Predictor of Vascular Disease Than Is PON1192 or PON155 Genotype

  2000cited by this paper
• Effects of different forms of dietary hydrogenated fats on serum lipoprotein cholesterol levels.

  1999cited by this paper
• Reduced postprandial serum paraoxonase activity after a meal rich in used cooking fat.

  1999cited by this paper
• Trans fatty acids and coronary heart disease.

  1999cited by this paper
• Polymorphism in high density lipoprotein paraoxonase gene and risk of acute myocardial infarction in men: prospective nested case-control study

  1999cited by this paper
• Daily moderate alcohol consumption increases serum paraoxonase activity; a diet-controlled, randomised intervention study in middle-aged men.

  1999cited by this paper
• Constantly low HDL-cholesterol concentration relates to endothelial dysfunction and increased in vivo LDL-oxidation in healthy young men.

  1999cited by this paper
• Atheroprotective mechanisms of HDL.

  1999cited by this paper
• Replacement of partially hydrogenated soybean oil by palm oil in margarine without unfavorable effects on serum lipoproteins

  1998cited by this paper
• Mice lacking serum paraoxonase are susceptible to organophosphate toxicity and atherosclerosis

  1998cited by this paper
• Paraoxonase inhibits high-density lipoprotein oxidation and preserves its functions. A possible peroxidative role for paraoxonase.

  1998cited by this paper
• Paraoxonase and coronary heart disease.

  1998cited by this paper
• Flow associated or flow mediated dilatation? More than just semantics.

  1997cited by this paper
• Individual fatty acid effects on plasma lipids and lipoproteins: human studies.

  1997cited by this paper
• Evidence for a paraoxonase-independent inhibition of low-density lipoprotein oxidation by high-density lipoprotein.

  1997cited by this paper
• Trans (elaidic) fatty acids adversely affect the lipoprotein profile relative to specific saturated fatty acids in humans.

  1997cited by this paper
• Stearic acid, trans fatty acids, and dairy fat: effects on serum and lipoprotein lipids, apolipoproteins, lipoprotein(a), and lipid transfer proteins in healthy subjects.

  1997cited by this paper
• Expression in Escherichia coli of soluble and M13 phage-displayed forms of a single-chain antibody fragment specific for digoxin: assessment in a novel drug immunoassay.

  1995cited by this paper
• Effects of partially hydrogenated fish oil, partially hydrogenated soybean oil, and butter on serum lipoproteins and Lp[a] in men.

  1995cited by this paper
• Dietary trans fatty acids: effects on plasma lipids and lipoproteins of healthy men and women.

  1994cited by this paper
• Antioxidative activity of high density lipoproteins in vivo.

  1993cited by this paper
• Relative and biomarker-based validity of a food-frequency questionnaire estimating intake of fats and cholesterol.

  1993cited by this paper
• Hydrogenation alternatives: effects of trans fatty acids and stearic acid versus linoleic acid on serum lipids and lipoproteins in humans.

  1992cited by this paper
• An Analytic Approximation to the Distribution of Lilliefors's Test Statistic for Normality

  1986cited by this paper

• Modulation of the antioxidant enzyme paraoxonase-1 for protection against cardiovascular diseases.

  2024cites this paper
• Modulatory Effect of Lifestyle-Related, Environmental and Genetic Factors on Paraoxonase-1 Activity: A Review

  2023cites this paper
• Presence, enzymatic activity, and subcellular localization of paraoxonases 1, 2, and 3 in human lung tissues.

  2022cites this paper
• Modification of High-Density Lipoprotein Functions by Diet and Other Lifestyle Changes: A Systematic Review of Randomized Controlled Trials

  2021cites this paper
• Factors associated to serum paraoxonase 1 activity in patients with cardiovascular disease

  2021cites this paper
• PON1 (Paraoxonase 1) Q192R Gene Polymorphism in Ischemic Stroke among North Indian Population

  2021cites this paper
• PON-1, Possible Biomarker for Diagnosis But Also for Risk in Diastolic Dysfunction with Preserved Ejection Fraction

  2019cites this paper
• The contribution of paraoxonase 1 and myeloperoxidase to HDL-cholesterol functionality

  2016cites this paper
• Trans fatty acids and cholesterol levels: An evidence map of the available science.

  2016cites this paper
• Effects of mono and dinuclear copper(II) complexes derived from non-steroidal anti-inflammatory drug naproxen on human serum paraoxanase1 (PON1) activity

  2015cites this paper
• Association of serum paraoxonase concentration with serum lipid levels and bone mineral density measurements in early postmenopausal women

  2015cites this paper
• Paraoxonase responses to exercise and niacin therapy in men with metabolic syndrome

  2015cites this paper
• Medicinal Plants in the Treatment of Diabetes Mellitus

  2014cites this paper
• Effect of diet on vascular health

  2014cites this paper
• Performance of two immobilized lipases for interesterification between canola oil and fully-hydrogenated canola oil under supercritical carbon dioxide

  2014cites this paper
• Pharmacogenetics of paraoxonase activity: elucidating the role of high-density lipoprotein in disease.

  2013cites this paper
• Dietary fatty acid intake is associated with paraoxonase 1 activity in a cohort-based analysis of 1,548 subjects

  2013cites this paper
• Serum Paraoxonase 1 Activity Is Associated with Fatty Acid Composition of High Density Lipoprotein

  2013cites this paper
• Intake of trans fat and all-cause mortality in the Reasons for Geographical and Racial Differences in Stroke (REGARDS) cohort.

  2013cites this paper
• HYPOLIPIDEMIC EFFECT OF GINGER EXTRACT IN VANASPATI FED RATS

  2013cites this paper
• Implications of serum paraoxonase activity in obesity, diabetes mellitus, and dyslipidemia

  2013cites this paper
• Paraoxonase 1 (PON1) Activity, Polymorphisms and Coronary Artery Disease

  2012cites this paper
• Effect of dietary lipids on paraoxonase-1 activity and gene expression.

  2012cites this paper
• The three-gene paraoxonase family: physiologic roles, actions and regulation.

  2011cites this paper
• Determinants of paraoxonase activity in healthy adults.

  2010cites this paper
• Diet and Paraoxonase 1 Enzymatic Activity in Diabetic Foot Patients from Romania and Belgium: Favorable Association of High Flavonoid Dietary Intake with Arylesterase Activity

  2010cites this paper
• Modulação dietética da atividade da paraoxonase : revisão de estudos em humanos

  2010cites this paper
• Variation in paraoxonase-1 activity and atherosclerosis

  2009cites this paper
• Age-Associated Decrease of High-Density Lipoprotein-Mediated Reverse Cholesterol Transport Activity

  2009cites this paper
• Modulação dietética das paraoxonases : revisão de estudos em humanos

  2009cites this paper
• Effect of consuming ground beef of differing monounsaturated fatty acid content on atherosclerotic cardiovascular disease risk factors in healthy men

  2009cites this paper
• The paraoxonase gene family and atherosclerosis

  2009cites this paper
• The evidence for dietary prevention and treatment of cardiovascular disease.

  2008cites this paper
• Dietary Modulation of Paraoxonase-1 Activity and Concentration in Humans

  2008cites this paper
• Cañones o margarina: la grasa trans y el riesgo cardiovascular

  2007cites this paper
• Reducing Trans Fats Consumption in Canada: Voluntary/Mandatory Labeling System or Trans Fats Ban?

  2007cites this paper
• Trans fats in cardiac and diabetes risk: An overview

  2007cites this paper
• Genetic and environmental determinants of the PON‐1 phenotype

  2007cites this paper
• Brief report: Nutrition and weight loss information in a popular diet book: Is it fact, fiction, or something in between?

  2006cites this paper
• Economic Impacts of Proposed Limits on Trans Fats in Canada

  2006cites this paper
• A role for FXR and human FGF-19 in the repression of paraoxonase-1 gene expression by bile acids Published, JLR Papers in Press, November 3, 2005.

  2006cites this paper
• Postprandial modulation of serum paraoxonase activity and concentration in diabetic and non-diabetic subjects.

  2006cites this paper
• Trans fatty acids and cardiovascular disease.

  2006cites this paper
• Composition, Structure and Absorption of Milk Lipids: A Source of Energy, Fat-Soluble Nutrients and Bioactive Molecules

  2006cites this paper
• The relation between trans fatty acid levels and increased risk of myocardial infarction does not hold at lower levels of trans fatty acids in the Costa Rican food supply.

  2006cites this paper
• Determinants of variation in serum paraoxonase enzyme activity in baboons Published, JLR Papers in Press, April 16, 2005. DOI 10.1194/jlr.M400473-JLR200

  2005cites this paper
• Modulation of paraoxonase (PON1) activity.

  2005cites this paper
• Consumption of argan oil may have an antiatherogenic effect by improving paraoxonase activities and antioxidant status: Intervention study in healthy men.

  2005cites this paper
• Commentary Modulation of paraoxonase (PON1) activity

  2005cites this paper
• The paraoxonase gene family and atherosclerosis.

  2005cites this paper
• Genetic and environmental factors modulating serum concentrations and activities of the antioxidant enzyme paraoxonase-1.

  2004cites this paper
• Dietary intake and coronary heart disease: A variety of nutrients and phytochemicals are important

  2004cites this paper
• Trans fatty acids, HDL-cholesterol, and cardiovascular disease. Effects of dietary changes on vascular reactivity.

  2003cites this paper
• Paraoxonase gene polymorphisms, oxidative stress, and diseases

  2003cites this paper